Received Oct 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 3 | — | — |
injections hurts; injections hurts; injections hurts; This spontaneous report was received from a medical assistant via a company employee. Medical assistant was referring to herself, a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On unknown dates, the patient was vaccinated with a total of 3 doses of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), Suspension for injection, (exact dose, route of administration, anatomical location, lot # and expiration date were not reported) as prophylaxis. This was a 3 dose series of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) vaccinations. The medical assistant reported, that the injections hurt. She said the 1st and 2nd dose hurt more than the 3rd. Date of adverse event was not provided. The patient recovered from all events on an unspecified date. The action taken with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) was reported as dose not changed (reported as therapy not withdrawn). The causal relationship was not provided. Batch/Lot number is being requested and will be submitted if received.